Hallucination induced by paroxetine discontinuation in patients with major depressive disordersYASUI-FURUKORI, Norio; KANEKO, Sunao.Psychiatry and clinical neurosciences (Carlton. Print). 2011, Vol 65, Num 4, pp 384-385, issn 1323-1316, 2 p.Article

Digitalis intoxication induced by paroxetine co-administrationYASUI-FURUKORI, Norio; KANEKO, Sunao.Lancet (British edition). 2006, Vol 367, Num 9512, pp 788-788, issn 0140-6736, 1 p.Article

Visual Hallucinations During Duloxetine Treatment in a Patient With Major Depressive DisorderTOMITA, Tetsu; YASUI-FURUKORI, Norio; KANEKO, Sunao et al.Clinical neuropharmacology. 2013, Vol 36, Num 5, pp 175-176, issn 0362-5664, 2 p.Article

Is breast-feeding of infants advisable for epileptic mothers taking antiepileptic drugs?LEI CHEN; FANG LIU; YOSHIDA, Shuichi et al.Psychiatry and clinical neurosciences (Carlton. Print). 2010, Vol 64, Num 5, pp 460-468, issn 1323-1316, 9 p.Article

Treatment of partial seizures with gabapentin : Double-blind, placebo-controlled, parallel-group studyYAMAUCHI, Toshio; KANEKO, Sunao; YAGI, Kazuichi et al.Psychiatry and clinical neurosciences (Carlton. Print). 2006, Vol 60, Num 4, pp 507-515, issn 1323-1316, 9 p.Article

Improvement of tardive dyskinesia following zopiclone treatmentSUGAWARA, Norio; YASUI-FURUKORI, Norio; KANEKO, Sunao et al.Progress in neuro-psychopharmacology & biological psychiatry. 2009, Vol 33, Num 4, pp 727-728, issn 0278-5846, 2 p.Article

Long-term observations of two siblings with Lafora disease treated with zonisamideYOSHIMURA, Ihoko; KANEKO, Sunao; YOSHIMURA, Noriaki et al.Epilepsy research. 2001, Vol 46, Num 3, pp 283-287, issn 0920-1211Article

Epilepsy, pregnancy, and the childKANEKO, Sunao.Epilepsia (Copenhagen). 2001, Vol 41, Num 9, pp 8-13, issn 0013-9580, SUPConference Paper

Effects of zonisamide on neurotransmitter exocytosis associated with ryanodine receptorsYOSHIDA, Shukuko; OKADA, Motohiro; GANG ZHU et al.Epilepsy research. 2005, Vol 67, Num 3, pp 153-162, issn 0920-1211, 10 p.Article

Molecular genetics of human familial epilepsy syndromesHIROSE, Shinichi; OKADA, Motohiro; KANEKO, Sunao et al.Epilepsia (Copenhagen). 2002, Vol 43, pp 21-25, issn 0013-9580, 5 p., SUP9Article

Genetic identifiers of EpilepsyKANEKO, Sunao; IWASA, Hiroto; OKADA, Motohiro et al.Epilepsia (Copenhagen). 2002, Vol 43, pp 16-20, issn 0013-9580, 5 p., SUP9Article

Zonisamide at clinically relevant concentrations inhibits field EPSP but not presynaptic fiber volley in rat frontal cortexHUANG, Chin-Wei; UENO, Shinya; OKADA, Motohiro et al.Epilepsy research. 2005, Vol 67, Num 1-2, pp 51-60, issn 0920-1211, 10 p.Article

Differential effects of the hiba odor on CNV and MMNHIRUMA, Tomiharu; YABE, Hirooki; SATO, Yasuharu et al.Biological psychology. 2002, Vol 61, Num 3, pp 321-331, issn 0301-0511Article

Effective electroconvulsive therapy in a 92-year-old dementia patient with psychotic featureKATAGAI, Hiroshi; YASUI-FURUKORI, Norio; KIKUCHI, Atsuhiro et al.Psychiatry and clinical neurosciences (Carlton. Print). 2007, Vol 61, Num 5, pp 568-570, issn 1323-1316, 3 p.Article

Pharmacological discrimination of protein kinase associated exocytosis mechanisms between dopamine and 3,4-dihydroxyphenylalanine in rat striatum using in vivo microdialysisGANG ZHU; OKADA, Motohiro; YOSHIDA, Shukuko et al.Neuroscience letters. 2004, Vol 363, Num 2, pp 120-124, issn 0304-3940, 5 p.Article

Both 3,4-dihydroxyphenylalanine and dopamine releases are regulated by Ca²⁺-induced Ca²⁺ releasing system in rat striatumGANG ZHU; OKADA, Motohiro; YOSHIDA, Shukuko et al.Neuroscience letters. 2004, Vol 362, Num 3, pp 244-248, issn 0304-3940, 5 p.Article

Bemegride Lengthens Seizure Duration During Electric Convulsive Therapy in a Schizophrenic Patient With Increased Seizure ThresholdKATAGAI, Hiroshi; YASUI-FURUKORI, Norio; KIKUCHI, Atsuhiro et al.The Journal of ECT. 2009, Vol 25, Num 1, pp 61-63, issn 1095-0680, 3 p.Article

Effects of ryanodine receptor activation on neurotransmitter release and neuronal cell death following kainic acid-induced status epilepticusMORI, Fumiaki; OKADA, Motohiro; TOMIYAMA, Masahiko et al.Epilepsy research. 2005, Vol 65, Num 1-2, pp 59-70, issn 0920-1211, 12 p.Article

Determination of exocytosis mechanisms of DOPA in rat striatum using in vivo microdialysisGANG ZHU; OKADA, Motohiro; YOSHIDA, Shukuko et al.Neuroscience letters. 2004, Vol 367, Num 2, pp 241-245, issn 0304-3940, 5 p.Article

Memory trace dependence on number of stimuli in magnetic mismatch negativityMATUOKA, Takashi; YABE, Hirooki; REN, Asai et al.Neuroreport (Oxford). 2008, Vol 19, Num 10, pp 1003-1007, issn 0959-4965, 5 p.Article

Personality types and coping style in hemodialysis patientsKIDACHI, Ruriko; KIKUCHI, Atsuhiro; NISHIZAWA, Yoshiko et al.Psychiatry and clinical neurosciences (Carlton. Print). 2007, Vol 61, Num 4, pp 339-347, issn 1323-1316, 9 p.Article

Determination of fluvoxamine and its metabolite fluvoxamino acid by liquid-liquid extraction and column-switching high-performance liquid chromatographyYASUI-FURUKORI, Norio; INOUE, Yoshimasa; KANEKO, Sunao et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 37, Num 1, pp 121-125, issn 0731-7085, 5 p.Article

The genetics of febrile seizures and related epilepsy syndromesHIROSE, Shinichi; MOHNEY, Robert P; OKADA, Motohiro et al.Brain & development (Tokyo. 1979). 2003, Vol 25, Num 5, pp 304-312, issn 0387-7604, 9 p.Article

Poor reliability of therapeutic drug monitoring data for haloperidol and bromperidol using enzyme immunoassayYASUI-FURUKORI, Norio; FURUKORI, Hanako; SAITO, Manabu et al.Therapeutic drug monitoring. 2003, Vol 25, Num 6, pp 709-714, issn 0163-4356, 6 p.Article

Significant dose effect of carbamazepine on reduction of steady-state plasma concentration of haloperidol in schizophrenic patientsYASUI-FURUKORI, Norio; KONDO, Tsuyoshi; MIHARA, Kazuo et al.Journal of clinical psychopharmacology. 2003, Vol 23, Num 5, pp 435-440, issn 0271-0749, 6 p.Article